Glaukos Price to Sales Ratio 2014-2022 | GKOS
Historical PS ratio values for Glaukos (GKOS) over the last 10 years. The current P/S ratio for Glaukos as of January 27, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Glaukos P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-01-27 |
48.04 |
|
8.04 |
| 2022-09-30 |
53.24 |
$5.98 |
8.91 |
| 2022-06-30 |
45.42 |
$5.99 |
7.58 |
| 2022-03-31 |
57.82 |
$6.15 |
9.41 |
| 2021-12-31 |
44.44 |
$6.27 |
7.09 |
| 2021-09-30 |
48.17 |
$6.33 |
7.60 |
| 2021-06-30 |
84.83 |
$6.27 |
13.53 |
| 2021-03-31 |
83.93 |
$5.29 |
15.85 |
| 2020-12-31 |
75.26 |
$5.07 |
14.84 |
| 2020-09-30 |
49.52 |
$5.03 |
9.85 |
| 2020-06-30 |
38.42 |
$5.17 |
7.44 |
| 2020-03-31 |
30.86 |
$6.06 |
5.09 |
| 2019-12-31 |
54.47 |
$6.29 |
8.66 |
| 2019-09-30 |
62.51 |
$6.22 |
10.05 |
| 2019-06-30 |
75.40 |
$5.87 |
12.85 |
| 2019-03-31 |
78.37 |
$5.49 |
14.26 |
| 2018-12-31 |
56.17 |
$5.16 |
10.89 |
| 2018-09-30 |
64.90 |
$4.84 |
13.41 |
| 2018-06-30 |
40.64 |
$4.68 |
8.69 |
| 2018-03-31 |
30.83 |
$4.64 |
6.64 |
| 2017-12-31 |
25.65 |
$4.44 |
5.78 |
| 2017-09-30 |
33.00 |
$4.14 |
7.98 |
| 2017-06-30 |
41.47 |
$3.86 |
10.74 |
| 2017-03-31 |
51.30 |
$3.45 |
14.87 |
| 2016-12-31 |
34.30 |
$3.14 |
10.91 |
| 2016-09-30 |
37.74 |
$3.39 |
11.12 |
| 2016-06-30 |
29.16 |
$3.19 |
9.14 |
| 2016-03-31 |
16.86 |
$8.50 |
1.98 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$2.298B |
$0.294B |
|
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
|
